Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647568 · ClinicalTrials.gov registry record
Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study
A clinical trial, sponsored by Dallas VA Medical Center.
- Completed
- Registry status
- 715
- Enrollment target
NCT01647568 is a clinical trial that has completed, run by Dallas VA Medical Center. The registered enrollment target is 715 participants.
The verdict
NCT01647568 has completed, sponsored by Dallas VA Medical Center.
- COMPLETED
- Registry status
- 715 participants
- Enrollment target
Study Summary
At our VA hospital, in general, it is the policy of our GI lab to not stop our patients anti-platelet therapy whenever they see us for a routine colonoscopy. We do this because we believe the risk of stopping these sort of medications outweigh the risks of a complication from a colonoscopy. Therefore, we are enrolling patients who are either on clopidogrel or prasugrel or not on any anti-platelet/anti-coagulant therapy that come to our GI lab routine colonoscopies. We perform the procedure just like we normally would and then follow-up with the patient 7 and 30 days after their procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 715 participants |
| Start Date | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01647568
The ClinicalTrials.gov registry entry for NCT01647568 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 715 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dallas VA Medical Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01647568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01647568 about?
NCT01647568 is a clinical study titled "Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study". At our VA hospital, in general, it is the policy of our GI lab to not stop our patients anti-platelet therapy whenever they see us for a routine colonoscopy. We do this because we believe the risk of stopping these sort of medications outweigh the risks of a complication from a colonoscopy. Therefo...
What is the current status of trial NCT01647568?
This trial is currently completed. The enrollment target is 715 participants. The study started on 2009-12.
Who is sponsoring clinical trial NCT01647568?
This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.